Trial to Evaluate the Safety and Immunogenicity of Priming Regimens of 426c.Mod.Core-C4b and Optional Boost Regimen With HIV Trimer BG505 SOSIP.GT1.1 gp140, Both Adjuvanted With 3M-052-AF + Alum in Healthy, Adult Participants Without HIV
Clinical trial NCT05471076 · COMPLETED
Trial details
- NCT number
- NCT05471076
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-22
- Primary completion
- 2025-12-23
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.